Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from BioNxt Solutions ( (TSE:BNXT) ).
BioNxt Solutions Inc. has proposed a shares-for-debt transaction with arm’s length creditors to extinguish approximately $2.7 million in outstanding obligations arising from 8% convertible debentures issued in December 2022. In full settlement of the principal and accrued interest, the company plans to issue 6,008,883 common shares at a deemed price of $0.45 per share, subject to customary conditions and a statutory four-month-and-one-day hold period under Canadian securities regulations, a move that will strengthen its balance sheet by converting debt into equity but dilute existing shareholders.
The most recent analyst rating on (TSE:BNXT) stock is a Sell with a C$0.41 price target. To see the full list of analyst forecasts on BioNxt Solutions stock, see the TSE:BNXT Stock Forecast page.
Spark’s Take on TSE:BNXT Stock
According to Spark, TipRanks’ AI Analyst, TSE:BNXT is a Neutral.
The score is driven mainly by very weak financial performance (losses, negative equity, rising debt, and ongoing cash burn) and bearish technicals (price below key moving averages with negative MACD). Valuation is difficult to assess given negative earnings and no dividend support, providing limited offset.
To see Spark’s full report on TSE:BNXT stock, click here.
More about BioNxt Solutions
BioNxt Solutions Inc. is a bioscience innovator focused on next-generation drug delivery technologies, diagnostic screening systems and active pharmaceutical ingredient development. Its proprietary sublingual thin-film, transdermal skin patch and oral enteric-coated tablet platforms target therapeutic areas such as autoimmune diseases, neurological disorders and longevity, with research and development operations in North America and Europe and a commercialization focus on European markets. The company’s shares trade on the Canadian Securities Exchange, the OTCQB market in the U.S., and in Germany.
Average Trading Volume: 80,388
Technical Sentiment Signal: Sell
Current Market Cap: C$58.47M
See more data about BNXT stock on TipRanks’ Stock Analysis page.